The first batch of an experimental Ebola vaccine is heading to Liberia and is expected to arrive Friday.
The shipment of 300 vials, produced by British drug maker GlaxoSmithKline (GSK) and the U.S. National Institutes of Health, is the first potentially preventative medicine to reach the country.
GSK hopes to immunise the first volunteer within the next few weeks. Healthcare workers tending Ebola patients will be among the first to receive it, and researchers hope to enroll up to 30,000 people, about a third of whom would receive the vaccine, the Guardian reports. Read more...
More about Vaccine, Us World, World, Ebola, and Gsk
